Two Sigma Investments
ALXA

Two Sigma Investments’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Two Sigma Investments’s Portfolio ALXA Stock Details ALXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-10,026
Closed -$52K – 2510
2013
Q3 		$52K Buy
+10,026
New +$47.2K ﹤0.01% 1780

Other funds holding ALXA

LPA
Lansdowne Partners Austria Vienna, Austria $29M AUM 40.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Two Sigma Investments's ALXA Position: Q4 2013 in Review

Two Sigma Investments sold out of Alexza Pharmaceuticals Inc (ALXA) in Q4 2013, closing a stake of 10,026 shares — an estimated $52K sold.

Two Sigma Investments first reported a position in ALXA in Q3 2013 and held it in 1 quarter. The position peaked at $52K in Q3 2013. 41 funds tracked by Wall St. Rank hold ALXA as of Q4 2013.

  • Two Sigma Investments reported no remaining Alexza Pharmaceuticals Inc position as of Q4 2013 after selling out during the quarter.
  • Two Sigma Investments sold 10,026 Alexza Pharmaceuticals Inc shares in Q4 2013, an estimated $52K.
  • Two Sigma Investments first reported a position in Alexza Pharmaceuticals Inc in Q3 2013 and held it in 1 quarter.
  • Two Sigma Investments's Alexza Pharmaceuticals Inc position peaked at $52K in Q3 2013.
  • 41 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q4 2013.

Based on Two Sigma Investments's 13F filing for Q4 2013, filed 14 Feb 2014.